Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964010757> ?p ?o ?g. }
- W1964010757 endingPage "1134" @default.
- W1964010757 startingPage "1125" @default.
- W1964010757 abstract "HER-2 is a transmembrane growth factor receptor recognized in overexpression as an independent adverse prognostic factor in several cancers. This study measured HER-2 overexpression in pancreatic adenocarcinoma at the genetic, transcriptional, and translational level. Expression was gauged with regard to stage, grade, and survival. Pancreatic adenocarcinoma samples (n = 30) were analyzed with immunohistochemical labeling for HER-2 protein, Quantitative real-time reverse transcriptase polymerase chain reaction (Q-RT-PCR) measurement of HER-2 mRNA and fluorescence in situ hybridization (FISH) analysis of HER-2 gene expression. HER-2 expression in benign pancreatic lesions (n = 10) provided a control. Five (17%) of the pancreatic adenocarcinomas scored maximal 3+ immunohistochemistry (IHC) labeling, seven (23%) had significantly increased expression of HER-2 mRNA, while only one (3%) exhibited low level HER-2 gene amplification. Ten (33%) tumors demonstrated aneuploidy. In general, concordance between methodologies was poor, but the best agreement was seen between FISH aneuploidy status and Q-RT-PCR mRNA overexpression (80% agreement), followed by IHC and Q-RT-PCR (73% agreement). The least agreement was seen between IHC and FISH aneuploidy status (67% agreement). Tumor stage was positively associated with HER-2 mRNA and protein expression, but tumor grade and other patient characteristics did not reach statistical significance. A poor survival outcome was demonstrated with positive HER-2 status in all three measures of overexpression (Kaplan-Meier log-rank score; P < 0.01 [IHC], P = 0.05 [Q-RT-PCR], P = 0.02 [FISH]). Discordance in expression at the nuclear, cytoplasmic, and cell surface levels highlights the limitations of immunohistochemical evaluation alone and stresses the need for further evaluation of response to anti-HER-2 targeted therapies in tumors displaying overexpression in gene copy, mRNA, and receptor protein." @default.
- W1964010757 created "2016-06-24" @default.
- W1964010757 creator A5023909548 @default.
- W1964010757 creator A5032567530 @default.
- W1964010757 creator A5033120835 @default.
- W1964010757 creator A5034795863 @default.
- W1964010757 creator A5037367588 @default.
- W1964010757 creator A5061530083 @default.
- W1964010757 creator A5063657901 @default.
- W1964010757 date "2005-09-01" @default.
- W1964010757 modified "2023-09-25" @default.
- W1964010757 title "Assessment of HER-2 Status in Pancreatic Adenocarcinoma" @default.
- W1964010757 cites W101318166 @default.
- W1964010757 cites W16294358 @default.
- W1964010757 cites W1943842037 @default.
- W1964010757 cites W1964717481 @default.
- W1964010757 cites W1977072117 @default.
- W1964010757 cites W2001868613 @default.
- W1964010757 cites W2004024517 @default.
- W1964010757 cites W2008980228 @default.
- W1964010757 cites W2015394676 @default.
- W1964010757 cites W2018904511 @default.
- W1964010757 cites W2030229250 @default.
- W1964010757 cites W2030753600 @default.
- W1964010757 cites W2040142253 @default.
- W1964010757 cites W2041254255 @default.
- W1964010757 cites W2042051621 @default.
- W1964010757 cites W2046638420 @default.
- W1964010757 cites W2058680827 @default.
- W1964010757 cites W2076097510 @default.
- W1964010757 cites W2090425589 @default.
- W1964010757 cites W2090723965 @default.
- W1964010757 cites W2108244474 @default.
- W1964010757 cites W2108795463 @default.
- W1964010757 cites W2109694492 @default.
- W1964010757 cites W2117115931 @default.
- W1964010757 cites W2123621585 @default.
- W1964010757 cites W2126117802 @default.
- W1964010757 cites W2141393790 @default.
- W1964010757 cites W2143146123 @default.
- W1964010757 cites W2152113072 @default.
- W1964010757 cites W2159459001 @default.
- W1964010757 doi "https://doi.org/10.1097/01.pas.0000160979.85457.73" @default.
- W1964010757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16096400" @default.
- W1964010757 hasPublicationYear "2005" @default.
- W1964010757 type Work @default.
- W1964010757 sameAs 1964010757 @default.
- W1964010757 citedByCount "53" @default.
- W1964010757 countsByYear W19640107572012 @default.
- W1964010757 countsByYear W19640107572013 @default.
- W1964010757 countsByYear W19640107572014 @default.
- W1964010757 countsByYear W19640107572015 @default.
- W1964010757 countsByYear W19640107572016 @default.
- W1964010757 countsByYear W19640107572017 @default.
- W1964010757 countsByYear W19640107572018 @default.
- W1964010757 countsByYear W19640107572019 @default.
- W1964010757 countsByYear W19640107572020 @default.
- W1964010757 countsByYear W19640107572021 @default.
- W1964010757 crossrefType "journal-article" @default.
- W1964010757 hasAuthorship W1964010757A5023909548 @default.
- W1964010757 hasAuthorship W1964010757A5032567530 @default.
- W1964010757 hasAuthorship W1964010757A5033120835 @default.
- W1964010757 hasAuthorship W1964010757A5034795863 @default.
- W1964010757 hasAuthorship W1964010757A5037367588 @default.
- W1964010757 hasAuthorship W1964010757A5061530083 @default.
- W1964010757 hasAuthorship W1964010757A5063657901 @default.
- W1964010757 hasConcept C104317684 @default.
- W1964010757 hasConcept C121608353 @default.
- W1964010757 hasConcept C126322002 @default.
- W1964010757 hasConcept C142724271 @default.
- W1964010757 hasConcept C160798450 @default.
- W1964010757 hasConcept C204232928 @default.
- W1964010757 hasConcept C2777542201 @default.
- W1964010757 hasConcept C2779672484 @default.
- W1964010757 hasConcept C2781182431 @default.
- W1964010757 hasConcept C30481170 @default.
- W1964010757 hasConcept C48023723 @default.
- W1964010757 hasConcept C54355233 @default.
- W1964010757 hasConcept C60644358 @default.
- W1964010757 hasConcept C71924100 @default.
- W1964010757 hasConcept C86803240 @default.
- W1964010757 hasConceptScore W1964010757C104317684 @default.
- W1964010757 hasConceptScore W1964010757C121608353 @default.
- W1964010757 hasConceptScore W1964010757C126322002 @default.
- W1964010757 hasConceptScore W1964010757C142724271 @default.
- W1964010757 hasConceptScore W1964010757C160798450 @default.
- W1964010757 hasConceptScore W1964010757C204232928 @default.
- W1964010757 hasConceptScore W1964010757C2777542201 @default.
- W1964010757 hasConceptScore W1964010757C2779672484 @default.
- W1964010757 hasConceptScore W1964010757C2781182431 @default.
- W1964010757 hasConceptScore W1964010757C30481170 @default.
- W1964010757 hasConceptScore W1964010757C48023723 @default.
- W1964010757 hasConceptScore W1964010757C54355233 @default.
- W1964010757 hasConceptScore W1964010757C60644358 @default.
- W1964010757 hasConceptScore W1964010757C71924100 @default.
- W1964010757 hasConceptScore W1964010757C86803240 @default.
- W1964010757 hasIssue "9" @default.
- W1964010757 hasLocation W19640107571 @default.